Walgreens enters clinical trials business through new unit

[June 16, 2022]  (Reuters) - Walgreens Boots Alliance Inc on Thursday launched a clinical trials business that aims to use patient data from its pharmacies to help drive up recruitment in studies conducted by drugmakers.

Best known for its chain of drugstores, Walgreens has been looking to expand beyond its core business and spent $5.5 billion last year to take majority stakes in two health care providers, VillageMD and CareCentrix.

With the clinical trials business, the company plans to use its vast trove of data and new services to help cut costs for drugmakers and capture a share of the roughly $83 billion market.

"This is yet another way we are building our next growth engine of consumer-centric healthcare solutions," said Ramita Tandon, Walgreen's chief clinical trials officer.

(Reporting by Manas Mishra in Bengaluru; Editing by Aditya Soni)

[© 2022 Thomson Reuters. All rights reserved.]
This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.